Celldex Therapeutics Inc (CLDX)
26.22
-0.18
(-0.68%)
USD |
NASDAQ |
Nov 21, 16:00
26.24
+0.02
(+0.08%)
Pre-Market: 20:00
Celldex Therapeutics Total Assets (Quarterly): 823.18M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 823.18M |
| June 30, 2024 | 845.59M |
| March 31, 2024 | 868.85M |
| December 31, 2023 | 465.63M |
| September 30, 2023 | 280.26M |
| June 30, 2023 | 299.31M |
| March 31, 2023 | 324.52M |
| December 31, 2022 | 352.74M |
| September 30, 2022 | 369.23M |
| June 30, 2022 | 402.96M |
| March 31, 2022 | 424.04M |
| December 31, 2021 | 444.65M |
| September 30, 2021 | 460.20M |
| June 30, 2021 | 204.55M |
| March 31, 2021 | 219.06M |
| December 31, 2020 | 235.84M |
| September 30, 2020 | 255.77M |
| June 30, 2020 | 261.40M |
| March 31, 2020 | 112.50M |
| December 31, 2019 | 122.93M |
| September 30, 2019 | 131.84M |
| June 30, 2019 | 142.24M |
| March 31, 2019 | 147.58M |
| December 31, 2018 | 155.81M |
| September 30, 2018 | 168.29M |
| Date | Value |
|---|---|
| June 30, 2018 | 178.38M |
| March 31, 2018 | 191.38M |
| December 31, 2017 | 315.62M |
| September 30, 2017 | 319.42M |
| June 30, 2017 | 346.07M |
| March 31, 2017 | 360.05M |
| December 31, 2016 | 383.36M |
| September 30, 2016 | 251.95M |
| June 30, 2016 | 271.21M |
| March 31, 2016 | 301.93M |
| December 31, 2015 | 337.58M |
| September 30, 2015 | 352.63M |
| June 30, 2015 | 383.22M |
| March 31, 2015 | 407.70M |
| December 31, 2014 | 248.01M |
| September 30, 2014 | 271.66M |
| June 30, 2014 | 297.59M |
| March 31, 2014 | 318.70M |
| December 31, 2013 | 347.10M |
| September 30, 2013 | 180.96M |
| June 30, 2013 | 196.23M |
| March 31, 2013 | 224.36M |
| December 31, 2012 | 125.54M |
| September 30, 2012 | 119.84M |
| June 30, 2012 | 122.13M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
112.50M
Minimum
Mar 2020
868.85M
Maximum
Mar 2024
388.66M
Average
338.63M
Median
Total Assets (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 391.15M |
| Electromed Inc | 48.92M |
| Xtant Medical Holdings Inc | 98.88M |
| Senseonics Holdings Inc | 96.33M |
| Myomo Inc | 16.31M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 37.27M |
| Shareholders Equity (Quarterly) | 785.90M |
| Current Ratio | 24.27 |